Method for production of reprogrammed cell using chromosomally unintegrated virus vector

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9127256
APP PUB NO 20110287538A1
SERIAL NO

13054022

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An objective of the present invention is to provide vectors for conveniently and efficiently producing ES-like cells in which foreign genes are not integrated into the chromosome. The present inventors discovered methods for producing ES-like cells from somatic cells using chromosomally non-integrating viral vectors. Since no foreign gene is integrated into the chromosome of the produced ES-like cells, they are advantageous in tests and research, and immunological rejection and ethical problems can be avoided in disease treatments.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ID PHARMA CO LTD2-10-2 FUJIMI CHIYODA-KU TOKYO 102-0071

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ban, Hiroshi Ibaraki, JP 28 294
Fusaki, Noemi Ibaraki, JP 4 31
Hasegawa, Mamoru Ibaraki, JP 145 1396
Yonemitsu, Yoshikazu Chiba, JP 36 159

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00